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Available online 10 April 2013Abstract Hematopoietic cord blood (CB) transplantations are performed to treat patients with life-threatening diseases.
Besides endothelial cells, the neonatal multipotent stromal cell subpopulations CDSCs (CB-derived stromal cells) and USSCs
(unrestricted somatic stromal cells) are like bone marrow (BM) SCs interesting candidates for clinical applications if detailed
knowledge is available. Clonal USSC compared to CDSC and BMSC lines differ in their developmental origin reflected by a
distinct HOX expression. About 20 (out of 39) HOX genes are expressed in CDSCs (HOX+), whereas native USSCs reveal no HOX
gene expression (HOX-). Moreover, USSCs display a lineage-specific absence of the adipogenic differentiation potential. As the
specific HOX code can be ascribed to topographic bodysites it may be important to match the HOX code of transplanted cells to
the tissue of interest. Herein co-culture experiments were performed, presenting a novel approach to modulate the
differentiation potency of USSCs towards HOX positive stromal cells. After co-culturing native USSCs with CDSCs and BMSCs,
USSCs adapt a positive HOX code and gain the adipogenic differentiation capacity. These results present for the first time
modulation of a lineage-specific differentiation potential by co-culture. Finally, USSCs can be claimed as potential candidates
to substitute unique progenitor cell populations in clinical approaches.
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usefulness in specific clinical applications. Therefore, a
detailed characterization of their developmental origin and
their lineage-specific differentiation potential is mandatory
to elaborate, if a specific cell source might be favourable for
bone and cartilage formation. Questionable as well is, if
mixed bulk cultures should be applied in clinical applica-
tions, as no detailed knowledge is available on the impact of
mixed subpopulations of stromal cells. In cord blood, two
distinct clonal neonatal subpopulations are described: USSCs
(unrestricted somatic stromal cells) and CDSCs (cord blood
derived stromal cells) (Kluth et al., 2010; Kogler et al., 2004;
Liedtke et al., 2010). Regarding their immunophenotype
both clonal neonatal cell types share the same pattern of
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similar to bone marrow-derived stromal cells (Erices et al.,
2002) and are commonly referred to as “MSCs” phenotype
(Dominici et al., 2006). However, the markers used to
describe stromal cells are not specific and are expressed by
many connective tissue cells that are not stem cells. To
date, a marker set clearly distinguishing connective tissue
stem cells from more mature cells is not available. As the
term “MSCs”, which can stand for mesenchymal stromal
cells as well as multipotent stromal cells, is controversially
discussed (Bianco, 2011a), we will refer to cells derived out
of cord blood (CDSCs and USSCs) and out of bone marrow
(BMSCs) as stromal cells in this paper.
A great advantage of these CDSCs and USSCs is their simple
isolation and expansion in vitro. Likewise, USSCs produce
functionally significant amounts of hematopoiesis-supporting
cytokines and are superior to BMSCs in expansion of CD34+ cells
from cord blood (Kogler et al., 2005). USSCs are therefore a
suitable candidate for stroma-driven ex vivo expansion of
hematopoietic cord blood cells for short-term reconstitution
or co-transplantation (Jeltsch et al., 2011). In the near future,
these cells may be applied to patients to reduce the graft-
versus-host disease, the most occurring side effect after
transplantation of hematopoietic stem cells or to support
hematopoiesis (Abdallah and Kassem, 2009). USSCs and CDSCs
share the osteogenic and chondrogenic differentiation
potential. In a recent study our group analysed in detail the
expression of osteogenic and chondrogenic marker genes
during differentiation defining the osteogenic signature of
USSCs, CDSCs, BMSCs and (umbilical cord) UCSCs (Bosch et al.,
2012). Based on the work of Kluth et al. (2010), it was
demonstrated that USSCs in contrast to CDSCs do not
differentiate naturally towards the adipogenic lineage, while
expressing the adipogenic inhibitor Delta-like 1 homolog
(DLK1) on a transcript but not on a secreted protein level. In
addition, expression of HOX genes is absent in USSCs, whereas
CDSCs revealed a typical positive HOX code similar to BMSCs
(Liedtke et al., 2010).
HOX genes are essential for normal development of
vertebrates by determining the positional identity along the
anterior-posterior body axis (Krumlauf, 1994). In humans, the
39 known HOX genes are distributed among four paralogous
clusters HOXA to HOXD, located in chromosomes 7, 17, 12 and
2, respectively. HOX genes are expressed sequentially 3´ to 5´
along the body axis during embryogenesis, termed “temporal
and spatial colinearity” (Kmita and Duboule, 2003). The typical
HOX code of a cell describes the specific expression of
functional active HOX genes in distinct tissues (Gruss and
Kessel, 1991). More importantly HOX genes may also have a
therapeutic application in near future. It was found that HOXD3
protein is upregulated during normal wound repair (Hansen et
al., 2003). The protein promotes angiogenesis and collagen
synthesis, but is absent in poorly healing wounds of genetically
diabetic mice. After adding HOXD3, the treatment resulted in
faster diabetic wound closure and tissue remodeling.
While the facial skeleton is formed by HOX negative neural
crest cells (Creuzet et al., 2002), the skeleton, originating from
mesoderm-derived progenitor cells, is usually HOX positive in
adults (Leucht et al., 2008). In bone regeneration experiments,
Leucht et al. revealed that the HOX negative mandibular
progenitor cells are favourable in bone repair as compared to
the HOX positive tibial progenitor cells (Leucht et al., 2008). Intheir experiments, HOX negative mandibular progenitor cells
started to express HOX genes after transplantation into a tibial
bone defect leading to bone repair. In contrast to that, HOX
positive tibial progenitor cells transplanted into a mandibular
defect failed to regenerate bone. This data is supported by
recent findings, suggesting the biological advantages of
HOX negative cells isolated from endoral sites (Lohberger
et al., 2012). The potency of a HOX negative cell to adapt
the HOX code of surrounding cells or tissues therefore
seems to be an important feature for regenerative approaches
but also for the normal development in the skeleton of the
fetus.
As HOX genes are able to translocate passively through
biological membranes, a technique applying a co-culture
method provides several advantages. In the work presented
here, USSCs (HOX−) with a restricted adipogenic potential
were co-cultured with CDSCs and BMSCs (HOX+) to test if
the USSCs are able to adapt a HOX positive expression
pattern. Additionally, changes of the lineage-specific cell
fate modulated by co-culture were monitored for osteo-
genic, chondrogenic and adipogenic differentiation in this
approach. Finally, following hypotheses were tested:Do USSCs have the potential to adapt the HOX expression
pattern of a surrounding celltype?
Can the differentiation capacity be switched to an
adipogenic direction by exposing USSCs to HOX positive
CDSCs able to generate adipocytes?
Is the osteogenic differentiation capacity of USSCs affected
by co-culture with CDSCs and BMSCs?
Can USSCs be claimed as potential candidates to substituteunique progenitor cell populations?
Material and methods
Generation and expansion of CB-derived cells
and BMSCs
USSCs and CDSCs were generated as described previously
(Bosch et al., 2012; Kluth et al., 2010). In brief, CB was
collected from the umbilical cord vein with informed consent
of themother.Mononuclear cells (MNC) were obtained by ficoll
(Biochrom, density 1.077 g/cm3) gradient separation followed
by ammonium chloride lysis of RBCs. 5–7 *106 CB MNC/ml
were cultured in DMEM low glucose (Cambrex) with 30% FCS
(Perbio), 10–7 M dexamethasone (Sigma-Aldrich), penicillin/
streptomycin and L-glutamine (PSG; Cambrex). Clonal popula-
tionswere obtained from cord blood by applying special cloning
cylinders. Cell lines were generated as described before and, as
soon as distinct, separate colonies were observed, a cloning
cylinder was attached on a single colony and cells were
trypsinated according to the standard protocol. BMSCs were
isolated using BM aspirated from the iliac crest of healthy
unrelated donors as previously described (Kluth et al., 2010).
Transfection of USSCs
The transfection of USSCs was performed using the
transfection reagent FuGENE® (Roche Applied Science,
Mannheim, Germany). The production of lentiviral particles
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three plasmids: envelope plasmid GALV TM, helper plasmid
pCD/NL-BH and the expression vector pCL6IEGwo containing
the eGFP sequence (Supplementary Fig. 1). The transfection
was done according to following protocol: Day 1: HEK293T
cell splitting 5 * 106 cells/10 cm Ø cell plate in DMEM (high
glucose), 10% FCS, 1% PSG. Day 2: HEK293T transfection:
DMEM (high glucose) + 5 μg of each plasmid DMEM (high
glucose) + 45 μl FuGENE® were mixed and incubated for
15 min at room temperature and added to HEK293T cultures
in DMEM (high glucose), 5% FCS, 1% Glutamin. Day 3: Target
cells were thawed (1 * 105 cells/six-well plate), HEK293T
culture medium was exchanged with DMEM (high glucose),
5% FCS, 1% PSG. Day 4: Infection of target cells: Extracellular
supernatant containing virus particles from HEK293T cul-
tures was sterile filtered (0.45 μm filter) and added to
target cells (pure and 1:4 diluted). Day 5: Medium change of
target cells (DMEM (low glucose), 30% FCS, 1% PSG).
Cell sorting
Cells with a high eGFP expression were sorted after
transfection if the percentage of eGFP-expressing cells was
below 85%. After discarding the supernatant, the cells were
washed twice with PBS/0.5% HSA and resuspended in 750 μl
PBS/0.5% HSA. The sorting was performed with a high speed
sorter MoFLo XDP (Beckman–Coulter) in the Core Flow
Cytometry Facility of the ITZ. After sorting cells were plated
on cell dishes for at least 24 h before analysis.
Co-culture experiments
For co-culture experiments, the same amount of USSCs and
CD/BMSCs was cultivated in one flask in normal cultivation
medium (DMEM (low glucose: 1 g/l), 30% FCS, 1% Penicillin/
Streptomycin, 1% L-glutamine) for 16 h or 5 days. To separate
the USSCs from CD/BMSCs, the USSCs were sorted via
eGFP-expression. A stringent sorting gate was applied ensur-
ing that 10% of highly GFP expressing cells were sorted
(Supplementary Fig. 2A). Reanalysis of sorted cells revealed a
purity of cells N98% (Supplementary Fig. 2B). After 24 h
subsequent to sorting, RNA was isolated for analysis of the
gene expression via PCR and Primeview Affymetrix Arrays.
After further passages (P) subsequent to sorting, the cells
were differentiated into adipogenic (1P and 3P), chondrogenic
(1P) and osteogenic (1P) direction. In the Supplementary Fig. 3
schematical procedure of co-culture experiments and subse-
quent analyses is depicted.
In vitro differentiation
USSCs, CDSCs and BMSCs were differentiated as described
previously (Bosch et al., 2012; Kluth et al., 2010). In brief, for
adipogenic differentiation the differentiation medium was
replaced twice a week, alternating induction (containing
dexamethasone, indomethacine, insuline and 3-Isobutyl-
1methylxantin) and cultivation medium (containing insulin).
To visualize the lipid vacuoles, the differentiated cells were
fixed with formaldehyde (4 °C, 20 min) and stained with oil
red O (Sigma Aldrich).For chondrogenic differentiation, the pelleted cells were
incubated for 21 days in medium containing dexametha-
sone, ascorbic-acid-2-phosphate, sodium pyruvate, insulin-
transferrin-selenium and TGFbeta1. The media were
changed twice a week. For Safranin O/Fast Green (Waldeck)
following standard protocol, the pellets were cut into
sections of 6 mm using a cryotom after being embedded in
Tissue Freezing Medium (Jung, Leica).
For osteogenic differentiation the medium containing
sodium L-ascorbate, β-glycerolphosphate disodium salt hydrate
and dexamethasone was changed twice a week for 14 days. To
detect mineralization, the differentiated cells were fixed with
cold ethanol (70%, 10 min) and stained with Alizarin Red S-
(Sigma-Aldrich) according to standard protocols. For quantifi-
cation of Alizarin red 800 μl of 10% acetic acid were added and
incubated for 30 min while shaking. The cells were detached
with a cellscraper and transferred to a 1.5 ml eppendorf tube.
Samples were vortexed for 30 s then heated at 85 °C for 10 min
and finally cooled down on ice for 5 min. After a centrifugation
step at 24,500 ×g for 15 min 500 μl of the supernatant were
mixed with 200 μl of 10% ammoniumhydroxide and photomet-
rically measured in a platereader (Bio-Tek Instruments Inc.) at
405 nm. Values of the respective negative control were
subtracted from differentiated cells.
Total RNA extraction and reverse transcription
Total RNA was extracted from cell lines and cell samples in a
40 μl volume applying the RNeasy Kit (Qiagen) according to
the manufacturer's instructions. Determination of RNA
concentrations was carried out by applying a Nanodrop
device (NanoDropTechnologies). Reverse transcription was
performed for 1 h at 50 °C using the First-strand cDNA
Synthesis Kit (Invitrogen) and the enclosed oligo(dT)20
primer. About 1000 ng total RNA was converted into
first-strand cDNA in a 20 μl reaction. All control reactions
provided with this system were carried out to monitor the
efficiency of cDNA-synthesis. Prior to PCR, the completed
first-strand reaction was heat-inactivated at 85 °C for at
least 10 min. Finally, cDNA was treated with RNaseH
according to the manufacturer's protocol.
RT-PCR and qPCR
RT-PCR was carried out with intron-spanning primers specific
for each HOX gene (Liedtke et al., 2010) (Thermo Scientific).
Either RPL13A or GAPDH was used as reference gene for
normalization. Approximately 15 ng of cDNA was used for
subsequent RT-PCR-analysis in a total volume of 25 μl
containing 1× PCR buffer, 0.2 μM of each primer, 1.5 mM
MgCl2, 0.2 mM each dNTP and 1 U Taq DNA Polymerase
(Invitrogen) at the following conditions: (1) 2 min at 95 °C for
initial denaturation and Taq Polymerase activation, (2) 30 s at
95 °C, 30 s at 56 °C, (3) 30 s at 72 °C for 35 cycles, 5 min at
72 °C for final extension of PCR products. PCR was performed
on a Mastercycler ep gradient S (Eppendorf). Subsequently,
aliquots of the RT-PCR products and related controls were
analysed on a 2% agarose gel by electrophoresis. qPCR was
carried out with SYBR® Green PCR Mastermix (Applied
Biosystems) using 50 ng template cDNA. All reactions were run
in duplicates/triplicates, respectively, on a Step One Plus
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tary Table. 1) were carefully examined and checked for their
specificity. Relative changes in gene expressionwere calculated
following the ΔΔCt-method with GAPDH or RPL13A as internal
standard. Relative gene expression was illustrated as mean
values.Immunocytochemistry
Immunocytochemical staining was performed using an
antibody to human HOXC10 protein (Abnova, 1:250 dilu-
tion). Secondary antibody (Rhodamine Red X-conjugated
AffiniPure Goat-Anti-Mouse IgG; Jackson Immunoresearch)
was applied in a 1:2000 dilution. For enhancement of the
native GFP-signal the anti GFP rabbit IgG antibody conju-
gated with Alexa Fluor 488 (Life technologies) was applied
1:250. All photographs were taken under the same param-
eters with a confocal Zeiss LSM 700 microscope and ZEN
2011 software.Microarray Gene Expression Analyses
Cell lines used for Microarray Gene Expression Analyses
were cultured for 4 days. Total RNA was extracted on day 4
according to the RNeasy Mini Kit protocol (Qiagen). RNA
preparations were checked for RNA integrity by Agilent
2100 Bioanalyzer. All samples in this study showed high
quality RNA Integrity Numbers (RIN) of 10. RNA was
quantified by photometric Nanodrop measurement.
Synthesis of cDNA and subsequent biotin labelling of cRNA
was performed according to the manufacturers' protocol (3´
IVT Express Kit; Affymetrix, Inc.). Briefly, 100 ng of total RNA
was converted to cDNA, followed by in vitro transcription and
biotin labelling of aRNA. After fragmentation labelled aRNAwas
hybridized to Affymetrix PrimeViewTM Human Gene Expression
Microarrays for 16 h at 45 °C, stained by streptavidin/
phycoerythrin conjugate and scanned as described in the
manufacturer's protocol.
Data analyses on digitized fluorescence signal intensities
were conducted with GeneSpring GX software (Vers. 12.1;
Agilent Technologies). Probes within each probeset were
summarized by RMA after quantile normalization of probe
level signal intensities across all samples to reduce inter-array
variability (Bolstad et al., 2003). Input data pre-processing
was concluded by baseline transformation to the median of all
samples.
After grouping of samples according to their respective
experimental condition (USSC d0, USSC 16 h and USSC 5 d,
three replicates each) a given probeset had to be
expressed above background (i.e. fluorescence signal of a
given probeset was detected within the 20th and 100th
percentiles of the raw signal distribution of a given array)
in at least 66% of replicates in any one of three groups to be
further analysed. Differential gene expression was statis-
tically determined by ANOVA analysis (p b 0.05), followed
by FDR correction for multiple testing (Benjamini–
Hochberg).
Annotation Lists containing 278 differentially expressed
probeset IDs were subjected to the “Functional Annotation
Cluster Tool” provided by DAVID Bioinformatics Resources(http://www. david.abcc.ncifcrf.gov/) (Dennis et al., 2003;
Huang da et al., 2009; Sherman et al., 2007).
Results
Co-cultivation of USSCs with either CDSCs or BMSCs
leads to the expression of HOX genes.
In a first approach, it was hypothesized that HOX negative
USSCs might have the potential to adapt the HOX code from
surrounding cells, as it was described in mice by Leucht et al.
for mandibular periosteal cells (HOX−), expressing HOX genes
after co-culture with tibial periosteal cells (HOX+) (Leucht et
al., 2008). CDSCs display a neonatal subpopulation differing
from USSCs by their positive HOX code. Therefore, we decided
to use this neonatal model system as it is likely that these
celltypes come in close contact in vivo. A transwell systemwas
applied to test this hypothesis. USSCs were co-cultured for
5 dayswith a CDSC line in the transwell insert. AfterwardsHOX
gene expression in USSCs was tested by conventional reverse
transcriptase PCR (RT-PCR). In none of the experiments
performed, USSCs developed a positive HOX expression
pattern (data not shown here). Thereby it can be excluded
that possible interactions affecting the HOX expression
applying transwells occur through soluble factors such as
cytokines or exosomes.
Supposing that direct cell-cell contacts are necessary to
manipulate neonatal HOX− USSCs, a direct co-culture system
was tested. In previous experiments several titrations of
USSCs with CDSCs were performed to exclude possible PCR
artefacts caused by residual CDSCs cells after sorting. CDSCs
cells were diluted with USSCs in a ratio of 1:1000, 1:100,
1:50 and 1:20 (Supplementary Fig. 4). After RT PCR, none of
the 39 HOX genes tested could be observed in the 1:100
dilution and only 2–3 of the most highly expressed HOX
genes were observed at a low level in the 1:50 and the 1:20
dilution. This result clearly demonstrates that except for
rare weak signals most likely deriving from highly expressed
HOX genes, no other HOX genes can be detected even if 5%
of HOX positive cells are present. In the following experi-
ments, GFP-labelled USSC lines were applied and strictly
sorted subsequently by fluorescence activated cell sorting
(FACS) after co-cultivation with either CDSCs or BMSCs. By
an extremely stringent sorting strategy we minimized the
possibility of interfering contamination to less than 2%
(Supplementary Fig. 2). Fig. 1 depicts exemplary results of
the first direct co-culture experiments. In Fig. 1A, the HOX
gene expression patterns of all native cell lines analysed in
the following experiments are illustrated. Individual USSC
lines tested revealed HOX gene expression after direct
co-culture for 5 days with either CDSCs or BMSCs (Fig. 1B).
The most abundant genes detected after co-culture were
the paralogous genes HOXA10, HOXC10 and HOXD10.
However, USSCs did not completely adapt the identical
HOX code of the co-cultivated cell line after 5 days of
co-culture. These results were confirmed on protein level by
immunocytochemistry for one of the most abundant HOX
gene HOXC10 (Fig. 2). This mandatory experiment proves
that USSC without co-culture display no HOXC10 expression
on protein level, whereas after co-culture, the HOXC10
protein was clearly detectable in GFP-expressing cells.
Figure 1 NativeHOX negative USSC lines revealedHOX gene expression after 5 days of co-cultivationwithHOX positive cell types. A: The
HOX gene expression patterns of all cell lines used in co-culture experiments were measured by RT-PCR. Intensity of product bands
was judged from negative “−” to strongly positive “+++” in a graduated manner (for examples see legend) and visualized by a heat
map. B: USSCs co-cultivated for 5 days with either CDSCs or BMSCs were sorted by FACS and subsequently tested for the expression
of 39 HOX genes and adipogenesis inhibitor DLK1 by RT PCR.
Figure 2 Co-staining of HOXC10 and GFP protein in USSCs after
co-culture with CDSCs. USSC2 was co-cultivated (CC) with CDSC1
for five days, sorted via FACS and plated on chamber slides for
immunohistochemical staining. All photographs were taken under
the same parameters with a Zeiss LSM 700 Microscope applying the
ZEN 2011 software. The scale is 100 μm.
638 S. Liedtke et al.Thereby the results presented on transcript level were
validated on protein level demonstrating within one single
cell co-expression of both markers.
In order to determine if USSCs can be manipulated by
other different HOX positive cell populations as well, the
osteosarcoma cell line SAOS-2 was co-cultivated with USSCs
to test this hypothesis. Supplementary Fig. 5A reveals that
USSC lines (n = 2) were able to express HOX genes after
co-culture with SAOS-2 cells whereas the most abundant
HOX genes were HOXC10 and HOXD10. The significance of
these results displays that generally co-cultivation of cells
might impact the HOX gene expression pattern of cells and
confirms the adaptiveness of USSCs to surrounding cells. In
order to test if other HOX negative cells harbour the same
adaptiveness, co-cultures of CDSCs with HOX negative cells
derived from the human mandibular bone were performed
as a biological control. Except for HOXD3, the mandibular
bone cells did not express additional HOX genes after this co-
culture experiment (Supplementary Fig. 5B). We expected to
get HOX gene expression in mandibular progenitor cells, as it
was described by Leucht et al. (2008) in mice, however, we
cannot rule out, that the cells we generated from the
mandibular bone display more fibroblastic cells instead of
real progenitor cells explaining this discrepancy. Moreover,
one important conclusion we can draw from this experiment
is, that contamination of residual CDSCs was sufficiently
minimized, as no additional HOX gene was detectable inco-cultured mandibular cells after sorting the cells by flow
cytometry.
In the following experiments it was tested if the
developed HOX code can be maintained during longtime
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cell line. Therefore, after 5 days of co-culture (with either
CDSCs or BMSCs) sorted USSCs were cultivated for up to
three additional passages and HOX gene expression was
evaluated in subsequent passages. RT-PCR revealed an even
higher amount of expressed HOX genes after subsequent
passaging of USSCs (Supplementary Fig. 5C). Either, the
existent HOX gene expression increased or other HOX genes
were newly expressed. In all experiments HOXB7, HOXC10
and HOXD10 seem to be the most stably expressed genes.
Interestingly, the amount of the adipogenic inhibitor DLK1
transcript decreased by subsequent passaging and was
finally absent in USSCs co-cultivated with CDSCs after
three additional passages.
Taken together these preliminary results have proven
that USSCs harbour the potential to develop a positive HOX
code which is not attenuated in later passages. Moreover,
the downregulation of the adipogenic inhibitor DLK1 in later
passages indicates that the adipogenic potential of USSCs
might have been affected by the co-culture experiment.USSCs develop an adipogenic differentiation potential
after co-culture with CDSCs.
In contrast to CDSC and BMSC lines, native USSCs are HOX
negative and possess no adipogenic differentiation potential.
In order to define if co-cultivated USSCs (HOX+) which
downregulate the adipogenic inhibitor DLK1 are able to
modulate their differentiation capacity, cells were differen-
tiated into the adipogenic lineage after 5 days of co-culture
with CDSCs and BMSCs. After 21 days of adipogenic differen-
tiation the cells were stained with Oil-Red O for visualisation
of lipid vacuoles (Fig. 3A). Fig. 3A demonstrates the ability of
USSCs to generate lipid vacuoles after co-culture with a CDSC
line for 5 days when adipogenic differentiation was started 1
passage after sorting. The resulting stainings clearly
uncovered lipid vacuoles in USSCs after co-culture. In the
USSC d0 control without co-culture no lipid vacuoles were
detectable. It is very unlikely that lipid vacuoles detectable in
such a high amount of cells result from residual CDSCs, as
further proliferation is strongly restricted by induction of
adipogenesis. The adipogenic differentiation was likewise
started 3 passages after sorting and revealed the same result
(Supplementary Fig. 6). Less lipid vacuoles could be detected
whereas in the d0 control no staining was visible supporting
the hypothesis that the adipogenic differentiation potential of
USSCs can be modulated by co-culture. The reduction of the
adipogenic ability can most likely be ascribed to the extended
passaging, as this is a common observation in CDSCs and USSCs
in long term culture. To confirm these results, the adipogenic
marker Adipocyte, C1Q and collagen domain containing
(ADIPOQ), and the adipogenic inhibitor Delta-like 1 homolog
(DLK1) were tested (Fig. 3B). The adipogenic related gene
ADIPOQ was not significantly regulated directly after co-
culture but was highly increased at day 21 of adipogenic
differentiation. The adipogenic inhibitor DLK1 increased
directly after co-culture but was completely downregulated
after adipogenic differentiation. As we expected the DLK1
gene to be downregulated directly after co-culture we
followed up the expression kinetics of DLK1 in subsequent
passages and tested USSC2 in an independent experiment withone CDSC line and one BMSC line (Supplementary Fig. 7). After
subsequent passaging of the USSCs, expression of the
adipogenic inhibitor DLK1 decreased after 5 days of co-
culture and was nearly absent after two additional passages.The chondrogenic and osteogenic differentiation
potential of USSCs is affected by co-culture.
To test if the adaption of the HOX gene expression has an
influence on the chondrogenic and osteogenic differentiation
potentials of the USSCs, the co-cultured undifferentiated
USSCs were analysed for genes related to the osteogenic/
chondrogenic lineage. For the osteogenic differentiation, the
markers Sp7 transcription factor (OSX), integrin-binding
sialoprotein (BSP), bone morphogenetic protein 2 (BMP2) and
bone morphogenetic protein 4 (BMP4) were used. Besides
other bone and cartilage associated genes like twist homolog 1
(TWIST1), parathyroid hormone-like hormone (PTHLH), runt-
related transcription factor 2 (RUNX2), msh homeobox 2
(MSX2), and forkheadbox F1 (FOXF1) genes specific for
cartilage like Sry-box 9 (SOX9), collagen 1 A1 (COL1A1) and
aggrecan (ACAN) were analysed.
After co-culture of USSCs (n = 3) with CDSCs 10 out of 12
genes tested revealed a differential expression in all three
independently measured USSCs (Supplementary Fig. 8).
Upregulated genes were BMP2, BMP4, PTHLH, ACAN and
FOXF1 and downregulated were BSP, RUNX2, SOX9,TWIST1
and MSX2. We applied a paired t-test to evaluate the
statistical significance of the regulation by comparison of
three individual USSC lines before and after co-culture.
However, only BSP revealed a significant downregulation.
Although a clear tendency of regulation was detectable, the
p value was not significant in all other cases due to the
biological variances between the individual cell lines.
We further wanted to test, if the regulations seen in qPCR
experiments in d0 samples have a visual impact on the
differentiation capacity of co-cultured USSCs. Therefore,
cells were differentiated into the chondrogenic direction in
a pellet culture and slices were stained with Safranin O
(Fig. 4). In Fig. 4 it is visible that co-cultured USSCs display a
less condensed chondropellet structure as compared to the
controls without co-culture. Furthermore, the amount of
proteoglycans is reduced in co-cultured USSCs reflected by a
weaker red staining. It appears that they adapt to the
co-cultured CDSC line, as the condensation of the respective
chondropellet is less condensed as well.
The adaption of the HOX gene expression influencing the
osteogenic differentiation potential was further analysed
applying a CDSC line with a weaker osteogenic differentia-
tion potential as compared to the three USSC lines used for
co-cultivation for 5 days. After co-culture, cells were
differentiated into the osteogenic direction for 14 days and
subsequently stained with Alizarin Red (Fig. 5A). The
staining revealed less calcification in the USSCs after
co-culture as compared to the native USSC lines at day 0.
The calcification was quantified to better judge the
difference of treated cells (Fig. 5B). These results signifi-
cantly confirm the lower osteogenic differentiation capacity
of USSCs after co-culture. As the CDSC line used in this
experiment possessed a weaker osteogenic differentiation
potential compared to the native USSCs, these results
Figure 3 USSCs reveal an adipogenic differentiation potential after five days of co-culture with CDSCs. A: USSC1-3 were
co-cultured (CC) for 5 days with CDSC1. After FACS sort cells were cultivated for 1 further passage and then differentiated into the
adipogenic direction for 21 days (d21). Exemplified light microscopic photographs of cells stained with Oil-red-O (detects neutral
triglycerides and lipids) at day 21 of adipogenic differentiation in differentiated (+) and control cells (−). Scale bar: 100 μm and
25 μm in the enlarged images. B: qPCR analysis detecting the expression of DLK1 and ADIPOQ at day 0, after 5 days of co-culture (CC)
and after co-culture and 21 days of adipogenic differentiation (d21). The gene expression is normalized in relation to RPL13A.
640 S. Liedtke et al.support the hypothesis, that USSCs adapt not only the HOX
code, but moreover adjust their differentiation potentials to
surrounding cells.Affymetrix array analysis revealed further potential
candidate genes involved in the modulation of USSCs
by co-culture.
In order to define potential candidate genes involved in
the modulation of USSCs by co-culture following sampleswere applied: USSC d0 (n = 3), USSC 16 h after co-culture
(n = 3), USSC 5d after co-culture (n = 3). Each USSC line
was co-cultivated with the CDSC line hybridized to one
additional array (CDSC d0). To first assess differentially
expressed genes between the native USSC d0 and
co-cultured USSCs after 16 h and 5d, a significance
analysis of the array data was accomplished yielding 278
probesets (for a gene list see Supplementary Table 2).
Subsequently, the Affymetrix IDs of significantly regulated
genes were subjected to a Functional Annotation Cluster
analysis (DAVID Bioinformatics Resources 2008 database
Figure 4 USSCs showed a chondrogenic differentiation potential before and after co-culture with CDSCs for five days. USSC1-3
were co-cultured (CC) for 5 days with CDSC1, sorted by FACS and afterwards differentiated into the chondrogenic direction for
21 days in a pellet culture. Exemplified light microscopic photographs of safranin O staining. The scale is 100 μm.
641Neonatal mesenchymal-like cells adapt to surrounding cellshttp://www.david.abbc.ncifcrf.gov/) (Dennis et al.,
2003; Huang da et al., 2009; Sherman et al., 2007). The
DAVID Functional Annotation Clustering tool analyses the
enrichment of differentially expressed genes in definedFigure 5 USSCs co-cultured with CDSCs for 5 days adjusted their
for 5 days with CDSCs, sorted by FACS and afterwards differentiat
microscopic photographs of cells stained with Alizarin red (detec
differentiation. The scale is 200 μm. B: Quantification of Alizarin refunctional categories thereby facilitating the biological
interpretation in a network context. Analysis outcome
revealed Gene Ontology (GO) terms functionally involved
in spliceosome/mRNA processing, epigenetic regulation,osteogenic differentiation potential. A: USSCs were co-cultured
ed into the osteogenic direction for 14 days. Exemplified light
ts calcium deposits) were performed at day 14 of osteogenic
d was measured in an ELISA reader at 405 nm.
Table 1 Functional Annotation Clustering of differentially expressed genes. A: Annotations related to bone morphogenesis and
pattern formation. B: Annotations related to epigenetic regulations. By applying the Affymetrix PrimeView array 278 probeset IDs
were found to be significantly differentially expressed in USSC d0 versus USSC 16 h and USSC 5d after co-cultivation with CDSCs.
The resulting gene list was further analysed by the DAVID Functional Annotation Clustering Tool to identify gene ontology (GO)
terms. This table displays 2 consequential Annotation Clusters of this approach and the respective genes. The count column
depicts the amount of genes involved in individual terms. Genes tested are labeled in bold letters.
Gene ontology annotation Count P_Value Benjamini Genes
A
Proximal/distal pattern formation 4 3.5OE−03 4.7OE−01 HOXA10, HOXA11, HOXA9, HOXA10
Pattern specification process 10 1.10E−02 6.30E−01 HOXA10, HOXA11, HOXA9, HOXC6,
HOXD10, HHIP, FOXF1, FLT1, KIF3A, SF3B1
Anterior/posterior pattern formation 7 1.20E−02 6.6OE−01 HOXA10, HOXA11, HOXA9, HOXC6,
HOXD10, KIF3A, SF3B1
Regionalization 8 1.80E−02 7.20E−01 HOXA10, HOXA11, HOXA9, HOXC6, HOXD10,
HHIP, KIF3A, SF3B1
Embryonic limb morphogenesis 4 1.10E−01 8.60E−01 HOXA10, HOXA11, HOXA09, HOXC6, HOXD10
Embryonic appendage morphogenesis 4 1.10E−01 8.60E−01 HOXA10, HOXA11, HOXA09, HOXC6, HOXD10
Embryonic morphogenesis 8 1.20E−01 8.70E−01 HOXA10, HOXA11, HOXA9, HOXA10, FOXF1,
CLF1, GRLF1, PPAP2B
Skeletal system development 8 1.40E−01 8.80E−01 HOXA10, HOXA11, HOXA9, HOXD10, COL1A1,
CLEC3B, WWOX
Limb morphogenesis 4 1.50E−01 8.90E−01 HOXA10, HOXA11, HOXA9, HOXD10
Appendage morphogenesis 4 1.50E−01 8.90E−01 HOXA10, HOXA11, HOXA9, HOXD10
Appendage development 4 1.60E−01 8.90E−01 HOXA10, HOXA11, HOXA9, HOXD10
Limb development 4 1.60E−01 8.90E−01 HOXA10, HOXA11, HOXA9, HOXD10
Sequence-specific DNA binding 10 4.10E−01 9.60E−01 HOXA10, HOXA11, HOXA9, HOXD10, FOS,
FOXF1, HSPD1, HNRNPA2B1, MAFK
B
Regulation of gene expression, epigenetic 6 3.90E−03 4.60E−01 ARID1A, DNMT1, ATF7IP, EIF2C1, HELLS, FOS
DNA methylation 4 4.00E−03 4.30E−01 DNMT1, ATF7IP, HELLS, FOS
DNA alkylation 4 4.00E−03 4.30E−01 DNMT1, ATF7IP, HELLS, FOS
DNA modification 4 9.90E−03 6.30E−01 DNMT1, ATF7IP, HELLS, FOS
One-carbon metabolic process 5 6.50E−02 8.30E−01 DNMT1, ATF7IP, HELLS, FOS, SHMT2
Biopolymer methylation 4 6.70E−02 8.20E−01 DNMT1, ATF7IP, HELLS, FOS
Methylation 4 8.40E−02 8.30E−01 DNMT1, ATF7IP, HELLS, FOS
Negative regulation of transcription 8 4.30E−01 9.70E−01 DNMT1, ATF7IP, HELLS, SUM01, SMARCE1,
AKIRIN2, GRLF1, ZFP161
Negative regulation of transcription,
DNA-dependent
5 7.10E−01 1.00E + 00 DNMT1, ATF7IP, HELLS, SMARCE1, ZFP161
Negative regulation of RNA metabolic process 5 7.30E−01 1.00E + 00 DNMT1, ATF7IP, HELLS, SMARCE1, ZFP161
Negative regulation of transcription from RNA
polymerase II promoter
3 8.80E−01 1.00 + 00 DNMT1, ATF7IP, ZFP161
642 S. Liedtke et al.pattern formation, nucleotide binding, DNA replication,
stress response, transcription regulation, ubiquitination,
cell cycle and common cellular processes (data not
shown). We further focussed on the clusters displayed in
Table 1A and B. All terms listed in Table 1A have a strong
association to the expression of HOX genes which are
mainly responsible for pattern formation, skeletal devel-
opment and embryonic morphogenesis. Most prominent
genes within this cluster were among others the FBJ
murine osteosarcoma viral oncogene homolog; FOS which
is a transcription factor playing a role in bone development
(Grigoriadis et al., 1995), the hedgehog-interacting pro-
tein; HHIP belonging to the hedgehog (Hh) gene family
encoding signaling molecules that are involved in regulat-
ing morphogenesis and collagen, typeI, alpha-1; COL1A1
one of the most prominent collagens of bone and importanttarget gene in treatment of osteogenesis imperfecta
(Chamberlain et al., 2004). These three genes were
regarded as potential candidate genes relevant in the
modulation of USSCs initialized by co-culture and there-
fore validated by qPCR (Fig. 6). COL1A1 was upregulated in
2 out of 3 cases. However, USSC1 revealed a strong COL1A1
expression already at day 0 which was downregulated after
5 days of co-culture with CDSC1. The expression level in all
USSC samples compared to the CDSC line was already
higher at day 0 compared to CDSC d0 and tended to
increase during co-culture. The expression of HHIP was
higher as well in USSCs at day 0 but strongly increased in all
samples after 16 h of co-culture. However, after 5 days of
co-culture the expression of HHIP decreased and reached
an even lower level as compared to native USSCs.
Moreover, HHIP appeared to be adjusted to the expression
Figure 6 Differentially expressed candidate genes COL1A1, HHIP and FOS were validated by qPCR: USSC lines (n = 3) were co-cultivated for 16 h (16 h) and for 5 days (5d) with
CDSC1 and then analysed directly for the markers COL1A1, HHIP and FOS in comparison to the parental cell line without co-culture (d0). The gene expression is normalized in relation
to GAPDH.
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644 S. Liedtke et al.level of the co-cultivated CDSC line. Regarding the
expression of FOS, the very strong downregulation (Fold
changes: USSC1 –46,48; USSC2 -8.13, USSC3 -80.44) was
observed in all USSC lines tested in accordance with the
Affymetrix microarrays (see Supplementary Table 2), fold
change: -12.22). Notably, FOS is one of the prominent
genes associated to the GO terms annotated to epigenetic
regulations (Table 1B). Taken together, the microarray
data confirmed our former results and helped to find
additional potential candidate genes involved in the cell
fate switch of USSCs after co-culture.Discussion
Although stromal cell populations can be isolated from
numerous human tissues (Fraser et al., 2006; Griffiths et al.,
2005; Kogler et al., 2009), their developmental origins remain
largely unknown and their characterization is discussed
controversially (Bianco, 2011a; Bianco, 2011b). USSCs display
a strong similarity to CDSCs and BMSCs in their
immunophenotype and their osteogenic and chondrogenic
differentiation potential in vitro, but differ in their restricted
adipogenic potential (Kluth et al., 2010). In 2010, we were
able to distinguish these two functionally distinct neonatal
stromal cell populations derived from cord blood additionally
on the HOX gene expression pattern (Liedtke et al., 2010). In
order to define if the limited adipogenic differentiation
potential in USSCs is reflected by the HOX gene expression,
co-culture experiments were performed. The hypothesis was
pursued that co-culture of USSCs (HOX−) with CDSCs and BMSCs
(HOX+) could be sufficient to adapt theHOX expression pattern
of a surrounding cell as it was shown before in mice for
periosteal progenitor cells (Leucht et al., 2008). For the first
time, the results of our study clearly demonstrate in detail that
adaption of the HOX code by co-culture is possible in the
human system for CB-derived subpopulations. Notably, the
adaption of the HOX code attends with a cell fate switch of
USSCs gaining an adipogenic differentiation potential. These
results imply that the adaptiveness of USSCs to surrounding
cells is an important feature when using these cells in
therapeutical approaches. In addition the impact of the
co-culture on the osteogenic differentiation capacity was
tested. Both USSC and CDSC lines can be easily differentiated
towards the chondrogenic and osteogenic lineage but can
individually differ in the content of proteoglycans in chondro-
genesis or in the level of mineralization during osteogenesis.
Co-cultured USSCs revealed an adaption to the CDSC line
reflected by a lower level of proteoglycans detected at day 21
of chondrogenic differentiation. Co-culture of a CDSCs with
lower mineralization than USSCs revealed an adjustment of
the USSCs to the mineralization level of the CDSCs. Further-
more, these results were confirmed on transcript level for
several osteo/chondro-associated genes.
Co-culture of CDSCs with USSCs revealed regulation of
osteo- and chondro-associated markers, from which BMP2,
BMP4, PTHLH, ACAN and FOXF1 were upregulated and BSP,
RUNX2, SOX9, TWIST1 and MSX2 were downregulated after
co-culture (Supplementary Fig. 8). Many different transcription
factors and regulatory signals are involved in the endochondral
ossification. The runt domain-containing transcription factor 2
(RUNX2) is necessary for osteoblast differentiation and thecorrect function of mature osteoblasts. Furthermore, RUNX2
plays an important role in chondrocyte maturation (Adams et
al., 2007; Long, 2012). Downstream of RUNX2, the Sp7
transcription factor (OSX) is essential for the embryonic as
well as the postnatal osteoblast and osteocyte differentiation
and function (Long, 2012). A negative regulator strongly
involved in endochondral ossification is the parathyroid
hormone-related protein (PTHLH). This protein promotes
chondrocyte proliferation and delays the differentiation,
ensuring a supply of proliferating chondrocytes needed for
skeletal growth. Expression of PTHLH negatively regulates
RUNX2, which is required for the chondrocyte maturation
(Adams et al., 2007). All of the transcription factors are
regulated by a variety of developmental signals, including
Hedgehog proteins, Notch signaling, Wnt signaling, BMP
signaling and FGF signaling (Long, 2012) confirmed by our
data. BMP2 is known to be upregulated during osteogenesis as
well as during adipogenesis (Ahrens et al., 1993) and we were
able to confirm this. MSX2 promotes osteoblast differentiation
independently of Runx2 and negatively regulates adipocyte
differentiation (Ichida et al., 2004). Our PCR results clearly
demonstrated a downregulation of MSX2. This is in agreement
with published literature (Takada et al., 2009) andmay support
the idea of an osteogenic to adipogenic switch in USSCs after
co-culture. This hypothesis is further validated by the adapted
osteogenic potential of USSCs co-cultured with a CDSC line
displaying a weaker osteogenic potential. After osteogenic
differentiation of co-cultured USSCs, adapted to the osteogen-
ic potential of the CDSC line as a significantly weaker
calcification level could be detected by Alizarin quantification.
Our results are further in agreement with the under-
standing of bone development accompanied by a temporal
reactivation of HOX genes in a close network with TGFβ/BMP
and Wnt signaling (Goldring et al., 2006).
The most downregulated gene involved in the TGFβ
pathway was FOS. The proto-oncogene FOS has been found
to be involved in the cell differentiation along the osteoclast/
macrophage lineages, consequently playing a role in bone
remodeling (Grigoriadis et al., 1994). Krosl et al. demonstrat-
ed that the upregulation of HOXB4, HOXA9 or HOXB3 leads to a
decrease in the expression of c-Fos in rat cells (Krosl and
Sauvageau, 2000). These results are in line with our findings
that the expression of FOS is down-regulated after HOX gene
expression is upregulated.
In addition to the TGFβ pathway Wnt signaling has been
connected to many different developmental events during
embryogenesis as well as to adult tissue homeostasis by
affecting mitogenic stimulation, cell fate specification and
differentiation (Logan and Nusse, 2004). Furthermore loss of
Wnt signalling causes a cell fate shift of preosteoblast from
osteoblasts to adipocytes (Song et al., 2012). The Affymetrix
gene expression analyses performed in this study confirmed
the data presented in this work. Gene ontology terms enriched
for differentially expressed genes reflected the processes
observed in USSCs. Beside typical cellular processes especially
the bone formation and patterning associated terms substan-
tiate our data. Most notably confirming the data presented for
HOX genes as well as for osteo-specific genes. One of genes
found to be most strongly regulated was FOS. Besides its
critical functions in bone development, FOS is suggested to be
involved in epigenetic regulations (Bakin and Curran, 1999)
reflecting the GO terms displayed in Table 1B. Therefore, FOS
645Neonatal mesenchymal-like cells adapt to surrounding cellsis supposed to be one of the most promising key players in the
processes described here.
Taken together, the results presented in this work clearly
demonstrate the adaptiveness of USSCs regarding their
differentiation potential.
After co-culture USSCs adjust their differentiation capac-
ities to the stromal cell lines used in the experiments. The
USSCs revealed HOX gene expression and an adipogenic
differentiation potential. As an adaption to the CDSC type
could be revealed in vitro, a molecular switching of
osteogenesis versus adipogenesis was initiated in USSCs by
simple co-culture experiments.
We are convinced that the spatio-temporal regulation of
HOX genes during fetal development can biologically reflect
the adaptiveness of cells presented here. It can be hypothe-
sized that USSCs can be regarded as developmentally earlier
cell type in cord blood as compared to CDSCs. Until now no
experiments were able to define the fetal origin of these cells.
A negative HOX code of cells seems to provide a more
unrestricted status of progenitor cells and this can be regarded
as a mandatory feature for cells to adapt to the surrounding
niche. Moreover, the positive HOX code of CDSCs seems to
restrict cells in their regenerative potential, as it was shown by
Leucht et al. (2008) for the HOX positive tibial progenitor cells.
Therefore a speculative explanation might be that cells,
already “imprinted” by their surrounding niche, loose their
adaptiveness reflected by the positive HOX code. Consequent-
ly this method provides important insights into molecular
regulations of this process. Moreover, USSCs can be claimed as
potential candidates to substitute unique progenitor cell
populations as Leucht et al. (2008) presented in mice that
not every progenitor cell has a sufficient regenerative capacity
leading to a complete bone repair dependent on the inherent
HOX code of the cell. Transferring these results from Leucht
and colleagues to our in vitro cell model the relevance of the
inherent HOX code of a cell not only reflects the developmen-
tal origin of a cell but moreover the inherent regenerative
potential of progenitor and/or stromal cells like the HOX
negative USSCs. Others just recently described differential
HOX gene expression reflecting distinct aortic cell populations
(Trigueros Motos et al., 2013). Their data support our
hypothesis that the inherent HOX code of a cell can moreover
be linked to functional differences as described here.
As USSCs seem to be unrestricted in their HOX gene
expression, the adaptiveness to the surrounding cells/niche
seems to be an important prerequisite of a progenitor cell to
adapt the regenerative potential. Further experiments will be
needed to validate these new findings in vivo to evaluate the
impact of the inherent HOX code with regard to clinical
applications. However, the experiments described here
clearly consolidate the necessity to better characterize
stromal cells and their inherent regenerative potential when
applying them in clinical approaches. We are convinced that in
this context the adaptiveness of cells is higher in HOX− cells as
compared to HOX+ cells, which seem to be more restricted.Conclusion
Our data present for the first time important insights into
possible modulations of cell fate decisions in the human
neonatal system initiated by direct co-culture experiments ofUSSCs with CDSCs and BMSCs. Furthermore, USSCs can be
claimed as potential candidates to substitute unique progen-
itor cell populations in clinical approaches.Acknowledgments
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